ImportRefusal LogoImportRefusal

IPSEN BIOPHARMACEUTICALS CANADA

⚠️ Moderate Risk

FEI: 3025483248 • Mississauga, Ontario • CANADA

FEI

FEI Number

3025483248

📍

Location

Mississauga, Ontario

🇨🇦

Country

CANADA
🏢

Address

5050 Satellite Dr Suite 5, , Mississauga, Ontario, Canada

Moderate Risk

FDA Import Risk Assessment

41.2
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
2
Unique Violations
4/6/2023
Latest Refusal
4/6/2023
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
11.2×30%
Recency
44.2×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
4/6/2023
65QDY02BOTOX
118NOT LISTED
75UNAPPROVED
Division of West Coast Imports (DWCI)

Frequently Asked Questions

What is IPSEN BIOPHARMACEUTICALS CANADA's FDA import refusal history?

IPSEN BIOPHARMACEUTICALS CANADA (FEI: 3025483248) has 1 FDA import refusal record(s) in our database, spanning from 4/6/2023 to 4/6/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. IPSEN BIOPHARMACEUTICALS CANADA's FEI number is 3025483248.

What types of violations has IPSEN BIOPHARMACEUTICALS CANADA received?

IPSEN BIOPHARMACEUTICALS CANADA has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about IPSEN BIOPHARMACEUTICALS CANADA come from?

All FDA import refusal data for IPSEN BIOPHARMACEUTICALS CANADA is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.